YNR061C Antibody

What is YNR061C and what cellular functions is it involved in?

YNR061C (also known as TSA2) is a gene in Saccharomyces cerevisiae that encodes a stress-responsive peroxiredoxin protein involved in cellular antioxidant defense mechanisms. This protein plays a crucial role in protecting yeast cells against oxidative stress by neutralizing reactive oxygen species (ROS), particularly hydrogen peroxide. TSA2 works in concert with TSA1 (another peroxiredoxin) to maintain redox homeostasis in yeast cells .

Methodology note: When studying YNR061C function, researchers should consider using quantitative PCR to measure expression levels under various stress conditions. For accurate results, normalize expression against multiple reference genes and validate findings with protein-level studies using specific antibodies.

How can I validate the specificity of YNR061C antibodies?

Validating antibody specificity for YNR061C requires multiple complementary approaches:

• Western blot analysis comparing wild-type yeast versus YNR061C deletion strains

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Cross-reactivity testing against closely related proteins (particularly TSA1)

• Epitope mapping to confirm binding to the intended protein region

These validation steps are essential as antibodies may display cross-reactivity with similar proteins, particularly given the sequence homology between TSA1 and TSA2 . Computational models that incorporate biophysical constraints can significantly improve predictions of antibody specificity, especially when discriminating between closely related targets .

What experimental controls are essential when using YNR061C antibodies?

When designing experiments with YNR061C antibodies, include these critical controls:

• YNR061C deletion strain (negative control)

• YNR061C overexpression strain (positive control)

• Pre-immune serum or isotype control antibodies

• Competition assays with purified recombinant YNR061C protein

• Technical replicates across different batches of antibodies

Under oxidative stress conditions, increased expression of YNR061C may affect antibody binding efficiency, requiring additional normalization controls to account for dynamic expression changes .

How can I detect post-translational modifications (PTMs) of YNR061C protein?

Detecting PTMs on YNR061C requires specialized approaches:

• Generation of modification-specific antibodies that recognize particular PTMs (acetylation, phosphorylation, etc.)

• Dual immunoprecipitation approach: first capturing total YNR061C, then probing with PTM-specific antibodies

• Mass spectrometry analysis of purified YNR061C to identify modification sites

Recent advances in antibody technology allow for the development of highly specific antibodies that can distinguish between different post-translational modifications of the same protein. As demonstrated in research on modified vimentin peptides, antibodies can be developed to recognize specific PTMs such as citrullination, carbamylation, and acetylation with high specificity .

What approaches can improve YNR061C antibody specificity for challenging research applications?

Enhancing antibody specificity for YNR061C involves:

• Epitope selection optimization focused on unique regions that differentiate YNR061C from homologous proteins

• Phage display selection against multiple related ligands to identify highly specific binders

• Computational design of antibody sequences with customized specificity profiles

• Counter-selection strategies to eliminate cross-reactive antibodies

Recent research demonstrates that biophysics-informed models trained on experimentally selected antibodies can disentangle different binding modes associated with specific ligands. This approach allows for the prediction and generation of novel antibody variants with enhanced specificity for closely related targets .

How can I study YNR061C expression changes during oxidative stress response?

To accurately quantify YNR061C expression during oxidative stress:

• Time-course experiments with graduated hydrogen peroxide exposure (0.5mM to 5mM)

• Quantitative PCR analysis synchronized with protein-level detection via western blotting

• Fluorescent reporter constructs fused to the YNR061C promoter for real-time monitoring

• Single-cell analysis to capture expression heterogeneity within populations

Research indicates that during prolonged hydrogen peroxide exposure, expression of TSA1 and TSA2 may be buffered through complex transcriptional mechanisms involving YAP1, a key oxidative stress response transcription factor . Appropriate experimental design should account for this buffering effect when measuring expression changes.

What is the optimal experimental design for studying YNR061C function using antibodies?

When designing experiments to investigate YNR061C function:

• Include both genomic and proteomic approaches in parallel

• Implement genetic validation using:

  • Gene deletion strains

  • Complementation studies

  • Reciprocal hemizygosity analysis

• Apply quantitative measurements with appropriate statistical power

• Consider strain background effects on antibody binding efficiency

Research has shown that different yeast genetic backgrounds can significantly influence oxidative stress tolerance. For example, studies comparing BY, RM, and YPS strains revealed complex genetic architectures underlying hydrogen peroxide resistance . When designing antibody-based experiments, these strain differences must be considered as they may affect protein expression levels and epitope accessibility.

How can I resolve discrepancies between antibody-based detection and genetic data for YNR061C?

When faced with contradictory results:

• Verify antibody specificity under the specific experimental conditions

• Implement orthogonal detection methods (RNA-seq, mass spectrometry)

• Consider post-transcriptional regulation that may cause divergence between mRNA and protein levels

• Examine potential aneuploidies that could affect gene dosage

Research has demonstrated that chromosome-scale duplications can significantly impact oxidative stress tolerance in yeast. Specifically, Chromosome IV disomy (which may contain YNR061C) has been shown to provide high oxidative stress tolerance by buffering the expression of stress-responsive genes . These genomic alterations can complicate interpretation of antibody-based studies if not properly accounted for.

How can I design antibodies with tailored specificity profiles for YNR061C and related proteins?

Creating customized antibodies involves:

• Integrated approach combining:

  • Phage display selection against multiple ligands

  • High-throughput sequencing

  • Machine learning with biophysical constraints

• Identification of different binding modes associated with particular ligands

• Computational design of novel antibody sequences not present in initial libraries

Recent research demonstrates that "biophysics-informed models trained on a set of experimentally selected antibodies and associates to each potential ligand a distinct binding mode, which enables the prediction and generation of specific variants beyond those observed in the experiments" . This approach can be applied to design antibodies that specifically recognize YNR061C while discriminating between closely related proteins like TSA1.

What techniques can effectively distinguish between wild-type YNR061C and mutant variants?

To differentiate between wild-type and mutant YNR061C:

• Development of mutation-specific antibodies using synthetic peptides

• Epitope mapping to identify antibody binding regions affected by mutations

• Competitive binding assays with wild-type and mutant recombinant proteins

• High-resolution microscopy combined with FRET-based approaches for structural analysis

When developing such specific antibodies, validation across multiple experimental platforms is essential to confirm specificity. Research on antibody design has shown that "the model successfully disentangles these modes, even when they are associated with chemically very similar ligands" , suggesting the feasibility of developing highly specific antibodies for subtle protein variants.

How should I analyze complex data from YNR061C antibody experiments in multi-strain studies?

For robust analysis of multi-strain data:

• Implement hierarchical statistical models that account for strain-specific effects

• Normalize antibody signals against multiple reference proteins

• Consider genetic linkage among variants that may influence detection

• Apply dimensionality reduction techniques to identify key patterns across strains

Research has shown that "linkage among genetic variants strongly influences how loci are detected" . When analyzing antibody-based detection across multiple yeast strains, researchers must consider how genetic linkage might affect protein expression patterns and consequently antibody binding efficiency.

What computational approaches can help resolve epitope-specific binding of YNR061C antibodies?

Advanced computational tools for epitope analysis include:

• Machine learning algorithms trained on experimental binding data

• Structural modeling to predict antibody-antigen interactions

• Biophysics-informed computational models that incorporate:

  • Binding energy calculations

  • Conformational dynamics

  • PTM-specific recognition patterns

Recent research demonstrates that "incorporating biophysical constraints into models can offer quantitative insights" and that "such modeling can not only predict physical features but also design new proteins with specific properties" . These approaches can be particularly valuable when designing and interpreting experiments using YNR061C antibodies with specific epitope recognition requirements.